DEEPWAVE PERCUTANEOUS NEUROMODULATION PAIN THERAPY SYSTEM— 510(k) K061166
Substantially EquivalentBiowave Corporation
FDA 510(k) clearance K061166 for DEEPWAVE PERCUTANEOUS NEUROMODULATION PAIN THERAPY SYSTEM, Substantially Equivalent on 2006-08-15. Applicant: Biowave Corporation.
Clearance details
- Applicant
- Biowave Corporation
- Product code
- Code NHI
- Advisory panel
- Neurology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- North Attleboro, MA, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.